Use of Bypassing Agents Prior to and Post Bypassing Agent Dosing Guidance During Emicizumab Prophylaxis: Analyses from the HAVEN 1 Study-MedSci.cn

Use of Bypassing Agents Prior to and Post Bypassing Agent Dosing Guidance During Emicizumab Prophylaxis: Analyses from the HAVEN 1 Study

Callaghan, M; Negrier, C; Young, G; Khoo, L; Mahlangu, J; Windyga, J; Oldenburg, J; Xu, J; Catalani, O; Asikanius, E; Adamkewicz, J; Shima, M

BRITISH JOURNAL OF HAEMATOLOGY, 2018; 181 (): 129

科室
- - 订阅+
  - 更多科室
工具
服务